ABOUT HUGEL

New Hope, Better Life

History

GLOBALIZATION

  • 2020
    10
    Received approval from China NMPA for botulinum toxin product, Letybo
    Broke ground for toxin no. 3 capacity
    09
    Acquired 80% stake of J World, PDO thread manufacturer
    06
    Merged with AB Bio Inc
    Submitted BLA for botulinum toxin in EU
    04
    Broke ground for new filler capacity
  • 2019
    12
    ‘WELLAGE’ obtained NMPA approval in China
    (4 basic skincare products, 3 sheet masks)
    Increased stake in Across to 83.83%
    11
    Obtained additional indication approval for
    botulinum toxin(crow’s feet)
    07
    Merged with Dongyang HC
    04
    Filed NDA for botulinum toxin in China
    01
    Received marketing approval for botulinum toxin in Taiwan
    Completed phase III clinical trial(Bless 1,2) for
    botulinum toxin in US/Poland/Germany
  • 2018
    10
    Established US subsidiary, Hugel America Inc
    09
    Launched premium HA filler ‘The Chaeum Style’
    07
    Completed phase III clinical trial for botulinum toxin in China
    01
    Merged with Hugel Pharma and Hugel Meditec
    Official launch of ‘WELLAGE One Day Kit’ product
  • 2017
    12
    Increased stake in Across to 65.06%
    10
    Obtained marketing approval for penile enhancement filler,
    ‘The Chaeum SHAPE 10’
    07
    Change in major shareholder to Leguh Issuer Designated Activity Company
    02
    Obtained marketing approval for botulinum toxin in Brazil
  • 2016
    11
    Obtained marketing approval for botulinum toxin in Russia
    06
    Obtained additional indication approval for
    botulinum toxin(foot deformity in pediatric cerebral palsy)
    05
    Received IND approval for phase III clinical trial for
    botulinum toxin in China
    04
    Obtained additional indication approval for
    botulinum toxin(post-stroke upper-limb spasticity)
    03
    Received IND approval for phase III clinical trial for
    botulinum toxin in Germany and Poland